Topical SGX302 for Mild-to-Moderate Psoriasis

Clinical trial NCT05442190 · COMPLETED

Trial details

NCT number: NCT05442190
Sponsor: Soligenix
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriasis Plaque Psoriasis Psoriasis Vulgaris

Start date: 2022-12-14
Primary completion: 2025-10-22
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.